sulfamethoxypyridazine has been researched along with Erythroblastosis Fetalis in 1 studies
Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, AK | 1 |
| Cevik, N | 1 |
1 other study available for sulfamethoxypyridazine and Erythroblastosis Fetalis
| Article | Year |
|---|---|
Hemolysis and jaundice in the newborn following maternal treatment with sulfamethoxypyridazine (kynex).
Topics: Black or African American; Erythroblastosis, Fetal; Female; Glucosephosphate Dehydrogenase Deficienc | 1965 |